Old Dominion Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Old Dominion Capital Management's NVS Position: Q3 2021 in Review
Old Dominion Capital Management reduced its Novartis (NVS) stake by 0.22% in Q3 2021, selling an estimated $990 and leaving 4,955 shares worth $405K. The position accounts for 0.09% of the portfolio, ranked #134.
Old Dominion Capital Management first reported a position in NVS in Q2 2019 and has held it in 10 quarters since. The position peaked at $453K in Q2 2021. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.
- Old Dominion Capital Management held 4,955 shares of Novartis worth $405K as of Q3 2021.
- Old Dominion Capital Management sold 11 Novartis shares in Q3 2021, an estimated $990.
- Novartis made up 0.09% of Old Dominion Capital Management's portfolio in Q3 2021, its #134 holding.
- Old Dominion Capital Management first reported a position in Novartis in Q2 2019 and has held it in 10 quarters since.
- Old Dominion Capital Management's Novartis position peaked at $453K in Q2 2021.
- 1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.
Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.